Fast food is everywhere in our society, and despite the appealing taste of these meals, they are typically high in fat, high in calories, and the portions are simply way too big
Some evidence has also found that semaglutide may help lower the risk of heart disease and other cardiovascular issues
Pool of Placebo- and Active-Controlled Trials The occurrence of adverse reactions was also evaluated in a larger pool of patients with type 2 diabetes participating in 7 placebo- and active-controlled glycemic control trials [see Clinical Studies (14)] including two trials in Japanese patients evaluating the use of OZEMPIC as monotherapy and add-on therapy to oral medications or insulin
Wegovy, approved in 2021, has shown significant results in promoting weight loss, with clinical trial participants losing an average of 17-18% of their body weight over 68 weeks
for %WL of 4.0, a dropout rate of 10% and 1% critical significance level, 62 patients (31 per group) would provide at least 95% power to detect an estimated difference of 10%WL with a 95% CI no wider than 8.0 to 12.0